“Skinny Labels” for Generic Drugs Under Hatch-Waxman

Source-supplied fields

Report metadata

Identifier

IF12700

Version

6

Product type

Resources

Status

Active

Published

Jul 27, 2026

Source updated

Jul 29, 2026, 8:10 am UTC

Authors: Kevin J. Hickey

Source topics: Intellectual Property, Prescription Drugs

Politically.com intentionally does not reproduce the report summary or full text. Use the official Congress.gov links above to read the product in its source context.

Structured Congress.gov references

Related federal bills

• S 1128A bill to establish special rules relating to information provided with respect to drug applications concerning method of use patents.
  118th Congress
• S 5573A bill to amend title 35, United States Code, to provide for a safe harbor from infringement of a method of use patent relating to drugs or biological products.
  118th Congress
• S 43A bill to amend title 35, United States Code, to provide for a safe harbor from infringement of a method of use patent relating to drugs or biological products.
  119th Congress
• HR 6485To amend title 35, United States Code, to provide for a safe harbor from infringement of a method of use patent relating to drugs or biological products.
  119th Congress